It’s a bad line generic esomeprazole magnesium The company’s attempt to sell itself for around $9.5 billion hit an impasse in recent weeks after lead bidder Amgen sought trial data about blood cancer drug Kyprolis – something that Onyx was reluctant to share, Reuters reported last week.